Please assess the completion status of the following clinical trial:

Trial Title: CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or females~* Between 18 and 65 years of age~* Of all ethnic groups~* BCCA participants with at least one contrast enhancing brain mass with a diameter ≥ 1 cm and consistent with metastatic carcinoma\*~* Able to give consent~* Willingness to participate in the study \* One additional healthy participant will be included in the study to perform a 'test-run' for the complicated MRI and infusion protocol.~Exclusion Criteria:~* Pregnancy~* Diabetes mellitus (self-reported or HbA1C ≥ 6.5%)~* Ferromagnetic implant or foreign metallic bodies (pacemaker, loose metal, etc.)~* Claustrophobia~* History of kidney disease and/or eGFR \< 60~* Abnormal fasting blood glucose (\<70mg/dL or \>125 mg/dL)~* Allergic to corn~* History of adverse reactions to gadolinium based contrast agents~* Poor performance status (Karnofsky PS\<70%)~* Previously received whole brain radiotherapy~* All lesions evident on imaging were previously treated with stereotactic radiosurgery~* The participants weigh more than 300lbs~* The participants had surgery in the last 6 weeks~* The participants have an intrauterine device~* The participants have cosmetic tattoos

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- dynamic glucose enhanced MRI after D-glucose injection (Type: EXPERIMENTAL): IV catheter preparation: Catheter will be placed in one arm. Fasting glucose levels measured with a glucometer using a 1-2 mL sample of blood. Only participants with normal fasting blood glucose levels (70-125 mg/dL) will proceed with the study. First IV catheter will monitor blood glucose every 10 min after bolus injection until it returns to normal. Second IV catheter is placed on the opposite arm for glucose infusion and GBCA (gadobutrol) infusion.~Glucose infusion protocol: Occurs when the participant is in the MRI. Bolus injection of hospital grade 25g of 50% dextrose solution over 1 min is to increase blood glucose concentrations to about 3-4 times the normal level. Blood glucose levels should return to normal levels within 30 to 60 min.~GBCA infusion protocol: Occurs when the participant is in the MRI; approximately 20 min after glucose infusion. Standard intravenous bolus injection of 0.1mM/kg of gadobutrol (Gadovist) at an injection rate of 5 mL/sec.

Based on this trial design, predict the completion outcome and termination type (if applicable).